All Peptides
BPC-157
A synthetic peptide derived from a protein found in gastric juice, studied mainly in animals for its potential to speed healing of tendons, ligaments, muscle, and the gut lining.
Growth HormoneCJC-1295
A synthetic analog of growth hormone releasing hormone (GHRH) that raises baseline growth hormone and IGF-1 levels, commonly stacked with ipamorelin in the peptide community.
Skin & Anti-AgingGHK-Cu
A naturally occurring copper-binding tripeptide widely used in topical skincare for its studied effects on collagen production and skin repair, also explored via injection in research settings.
Growth HormoneIpamorelin
A selective growth hormone secretagogue (a ghrelin receptor agonist) studied for stimulating the body's own growth hormone release, valued in the peptide community for a comparatively mild side-effect profile.
Skin & Anti-AgingMelanotan II
A melanocortin receptor agonist originally researched as a sunless tanning agent, known for stimulating melanin production; not FDA-approved and associated with a more notable side-effect profile than its derivative PT-141.
Sexual HealthPT-141
A melanocortin receptor agonist, FDA-approved by prescription (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women, and used off-label/via research channels for libido in both sexes.
Weight ManagementSemaglutide
A GLP-1 receptor agonist that is FDA-approved by prescription for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy), known for significantly reducing appetite.
Growth HormoneSermorelin
A growth hormone releasing hormone (GHRH) analog that was previously FDA-approved (as Geref, discontinued) and is now most often used off-label/compounded to support the body's natural GH production, especially in age-related GH decline.
Healing & RecoveryTB-500
A synthetic fragment based on Thymosin Beta-4, a naturally occurring protein involved in cell migration and repair, studied for its potential role in wound healing, flexibility, and recovery from soft-tissue injury.
Weight ManagementTirzepatide
A dual GIP/GLP-1 receptor agonist, FDA-approved by prescription for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), often associated with greater average weight loss than single-hormone GLP-1 drugs.